Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Dr. Bendell on the Next Steps Following Progression on Immunotherapy in MSI-H CRC

January 4th 2018

Johanna C. Bendell, MD, medical oncologist, Sarah Cannon Research Institute, discusses the next steps following progression on checkpoint inhibitors in microsatellite instability-high (MSI-H) colorectal cancer (CRC).

Dr. Eng on Ongoing Studies for BRAF-Mutant CRC

January 3rd 2018

Cathy Eng, MD, professor of gastrointestinal medical oncology, The University of Texas MD Anderson Cancer Center, discusses ongoing trials investigating treatment for patients with BRAF-mutant colorectal cancer (CRC).

Dr. Abou-Alfa on Checkpoint Inhibitors in Liver Cancer

January 3rd 2018

Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses checkpoint inhibitors in liver cancer.

Precision Medicine Advancing GI Malignancies Field

January 2nd 2018

Luis A. Diaz, MD, discusses the precision medicine approaches available and in development for the treatment of patients with GI malignancies.

FDA Grants Priority Review to Novel Iobenguane I-131 Agent for Rare Neuroendocrine Tumors

December 29th 2017

The FDA has granted a priority review designation to a novel version of the radiopharmaceutical iobenguane I-131 for patients with malignant or recurrent pheochromocytoma or paraganglioma.

Von Hoff's Quest Is for a Cure in Pancreatic Cancer

December 27th 2017

Daniel D. Von Hoff, MD, is focused on developing more targeted therapies for those with pancreatic and other advanced cancers.

Molecular Testing Advancements Leading Field of GI Cancers

December 26th 2017

Shirley Michelle Shiller, DO, discusses progress with precision medicine for patients with gastrointestinal cancers.

Dr. Marshall Discusses Frontline Treatment for CRC

December 22nd 2017

John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses frontline treatment options for patients with colorectal cancer (CRC).

Gastric/GEJ Cancers: Looking Toward the Future

December 22nd 2017

The Evolving Treatment Landscape in Gastric/GEJ Cancers

December 22nd 2017

Gastric/GEJ Cancers: Non-Immunotherapeutic Advancements

December 22nd 2017

Other Immunotherapy Approaches in Gastric/GEJ Cancers

December 22nd 2017

Emerging Nivolumab Strategies in Gastric/GEJ Cancers

December 22nd 2017

Practical Considerations for Prescribing Immunotherapy

December 22nd 2017

MSI Testing's Impact on Immunotherapy in Gastric Cancers

December 22nd 2017

Immunotherapy in Advanced/Metastatic Gastric/GEJ Cancers

December 22nd 2017

Advanced/Metastatic Gastric Cancer: Beyond Frontline

December 22nd 2017

Treating Unresectable or Metastatic Gastric/GEJ Cancers

December 22nd 2017

Upfront Therapy Approaches in Gastric/GEJ Cancer

December 22nd 2017

Understanding Prognoses of Advanced Gastric/GEJ cancers

December 22nd 2017